Literature DB >> 12170878

Hepatitis C and the skin.

J Mark Jackson1.   

Abstract

Hepatitis C is an important and common cause of chronic hepatitis and cirrhosis. Cutaneous manifestations are often the first signs of infection. Dermatologists must be aware of these manifestations, because early diagnosis is the best treatment. HCV Ab by ELISA should be ordered in patients with LCV-urticarial vasculitis, cryoglobulinemia, lichen planus, Sjögren's syndrome, unexplained pruritus, PCT, PAN, chronic urticaria, patients starting methotrexate, unexplained pruritus, and any patient initiating therapy with a potentially hepatotoxic drug.

Entities:  

Mesh:

Year:  2002        PMID: 12170878     DOI: 10.1016/s0733-8635(02)00013-x

Source DB:  PubMed          Journal:  Dermatol Clin        ISSN: 0733-8635            Impact factor:   3.478


  8 in total

1.  The prevalence of HCV antibodies in skin disease patients in Saudi Arabia.

Authors:  Mona Halawani; Amal Balbisi; Hend Alotaibi; Fahed Alsaif; Talal M Bakir
Journal:  Saudi Pharm J       Date:  2009-12-24       Impact factor: 4.330

Review 2.  Rheumatic manifestations of hepatitis C virus chronic infection: Indications for a correct diagnosis.

Authors:  Carlo Palazzi; Emilio D'Amico; Salvatore D'Angelo; Michele Gilio; Ignazio Olivieri
Journal:  World J Gastroenterol       Date:  2016-01-28       Impact factor: 5.742

Review 3.  Morphologic features of extrahepatic manifestations of hepatitis C virus infection.

Authors:  Huaibin M Ko; Juan C Hernandez-Prera; Hongfa Zhu; Steven H Dikman; Harleen K Sidhu; Stephen C Ward; Swan N Thung
Journal:  Clin Dev Immunol       Date:  2012-08-05

4.  Hepatitis C virus core protein triggers abnormal porphyrin metabolism in human hepatocellular carcinoma cells.

Authors:  Takafumi Nakano; Kyoji Moriya; Kazuhiko Koike; Toshiharu Horie
Journal:  PLoS One       Date:  2018-06-01       Impact factor: 3.240

Review 5.  [Vasculitis associated with viral infections].

Authors:  Pascal Cohen; Loïc Guillevin
Journal:  Presse Med       Date:  2004-11-06       Impact factor: 1.228

6.  Skin manifestations associated with systemic diseases - Part II.

Authors:  Juliana Martins Leal; Gabriela Higino de Souza; Paula Figueiredo de Marsillac; Alexandre Carlos Gripp
Journal:  An Bras Dermatol       Date:  2021-09-17       Impact factor: 1.896

7.  Borderline tuberculoid leprosy and type 1 leprosy reaction in a hepatitis C patient during treatment with interferon and ribavirin.

Authors:  Mônica Santos; Emily dos Santos Franco; Paulo Luis da Costa Ferreira; Wornei Silva Miranda Braga
Journal:  An Bras Dermatol       Date:  2013 Nov-Dec       Impact factor: 1.896

8.  Apoptosis and clinical severity in patients with psoriasis and HCV infection.

Authors:  Sami A Gabr; Mohamed Y Berika; Ahmad H Alghadir
Journal:  Indian J Dermatol       Date:  2014-05       Impact factor: 1.494

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.